Analysts are increasingly positive about Shanghai Haohai Bio...
Analysts are increasingly positive about Shanghai Haohai Biological Technology's performance, despite growth prospects slower than the industry average. They believe the company's intrinsic value is on an upswing.
Revenue Beat: Shanghai Haohai Biological Technology Co., Ltd. Beat Analyst Estimates By 102%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment